HemOnc.org - A Free Hematology/Oncology Reference
|Regimens: 3,922||Regimen variants: 5,789||Studies: 6,196||References: 7,061|
|Solid Tumors||Malignant Hematology||Pediatrics||Transplant||Classical Hematology|
Links to all main disease pages
|Pediatric CNS malignancies|
|Low-grade glioma||High-grade glioma||Medulloblastoma|
|Pediatric hematologic neoplasms|
|B-cell acute lymphoblastic leukemia (B-ALL)||B-ALL, Ph+||T-cell acute lymphoblastic leukemia (T-ALL)||Acute myeloid leukemia (AML)|
|Anaplastic large cell lymphoma (ALCL)||Chronic myelogenous leukemia (CML)||Hodgkin lymphoma||Non-Hodgkin lymphoma (NHL)|
|Pediatric solid tumors|
|Epithelioid sarcoma||Ewing sarcoma||Hepatoblastoma||Neuroblastoma|
|Stem cell mobilization||Allogeneic HSCT||Autologous HSCT||Graft versus host disease (GVHD)|
Created as a knowledge base for hematology & oncology providers, HemOnc.org is a collaborative wiki containing details about hundreds of hematology/oncology drugs, and thousands of treatment regimens. Content is added by hematology & oncology professionals, and undergoes continuous peer review.
Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details.
Priorities of this project include:
- Creating a database of all approved systemic anticancer therapy agents and supportive medications used in the field of hematology/oncology.
- Creating a database of all standard-of-care systemic anticancer therapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
- Sample order sets and examples of supportive medications used with treatment regimens
- Aggregating useful links to existing resources by disease, such as guidelines, information about prognosis, clinical calculators, staging, and patient resources.
- Creating, maintaining, and disseminating a formalized ontology of anticancer drugs and regimens.
Additional possibilities for this project may include:
- Creating synopses of pivotal clinical trials and regimens
- Prioritizing regimens by their efficacy and/or toxicity
- Capturing historical regimens that were standard-of-care prior to 2005
- Checklists for common clinical scenarios/diseases
- Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects
The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.